NCT06080893View on ClinicalTrials.gov

The Effect of Preoperative Ferric Carboxymaltose Administration on Mortality in Geriatric Hip Fractures

PHASE4CompletedINTERVENTIONAL

Enrollment

209

Participants

Timeline

Start Date

October 10, 2023

Primary Completion Date

June 10, 2024

Study Completion Date

March 24, 2025

Conditions

Hip FracturesAnemiaComplication,Postoperative

Interventions

DRUG

Ferric carboxymaltose

"FCM can be administered in a short IV infusion of 15-20 minutes, allowing doses of 2 g in a single session, and furthermore, FCM is excellently tolerated and safe for patients.~FCM will be administered intravenously at preop 24th hour according to weight and preop hgb level"

Trial Locations (1)

34093

Istanbul University, Istanbul Faculty of Medicine, Department Orthopaedics and Traumatology, Istanbul

All Listed Sponsors

lead

Istanbul University

OTHER

NCT06080893 - The Effect of Preoperative Ferric Carboxymaltose Administration on Mortality in Geriatric Hip Fractures | Biotech Hunter | Biotech Hunter